Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2012/09/002947
CTRI/2012/09/002947
Completed
Phase 4

Comparative evaluation of efficacy and safety profile of Rhubarb and alpha-Keto analogue of amino acid supplementation on patients of Chronic Kidney Disease.

Department Of Pharmacology And Department Of Medicine0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Chronic kidney disease

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Chronic kidney disease
Sponsor
Department Of Pharmacology And Department Of Medicine
Enrollment
100
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department Of Pharmacology And Department Of Medicine

Eligibility Criteria

Inclusion Criteria

  • •Chronic kidney disease of different etiology, before ESRD.
  • •Patient not on dialysis.

Exclusion Criteria

  • •Acute infection
  • •Psychotic patient
  • •Critically ill patient
  • •HIV/HBsAg/Anti\-HCV and immunocompromised patient.
  • •Severe Renal pathology such as malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Study to compare which iron preparations is better for treatment of anaemic in patients of chronic kidney disease.
CTRI/2017/08/009343Jawaharlal Nehru Medical College Hospital
Recruiting
Phase 4
To know the safety and efficacy of Antioxidants in Patients of chronic obstructive pulmonary disease.Health Condition 1: null- Chronic obstructive pulmonary disease (COPD)
CTRI/2015/01/005432Jawaharlal Nehru Medical College and Hospital Aligarh Muslim University Aligarh150
Active, not recruiting
Not Applicable
Dexmedetomedine intravenous sedation on patients with and without Beta blockersHealth Condition 1: null- Retinal Disorder Patients requiring SurgeryHealth Condition 2: H431- Vitreous hemorrhage
CTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1
IRCT20130812014333N145Kermanshah University of Medical Sciences80
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19
IRCT20130812014333N147Kermanshah University of Medical Sciences80